Korro Bio, Inc. (KRRO) - Sotuvning sof marjinal rentabelligi

korrobio.com (KRRO) - korporativ logo

Korro Bio, Inc. (KRRO) RNA tahrirlash orqali oqsillar nuqsonlarini moslashuvchan tarzda tuzatishga e'tibor qaratadi. Sof foyda marjasi ushbu strategiyaning salohiyatini tasdiqlaydi, bunda -8214.50 ko'rsatkichi maqsadli daraja vazifasini o'taydi. AI tomonidan boshqariladigan loyihalash va sintezni robotlashtirish orqali progress tezlashmoqda. Shu bilan birga, kompaniya asosiy patentlar ustidan to'liq nazoratni saqlagan holda, dastlabki bosqichdagi sinovlarni tashqi laboratoriyalarga topshiradi.

KRRO: Korro Bio Kompaniya sotuv marjasi 21.02.2024 - 19.11.2026

Korro Bio (KRRO) - koʻrsatkichlar kesimi va moliyaviy hisobotlar

- bozor qiymati va tahlilchilarning maqsadli prognozi:
Kompaniyaning jamlanma tahliliyoti:Korro Bio, Inc.
korrobio.com ishlab chiqargan mahsulot

Sotuv marjasi barcha operatsion xarajatlar va soliqlarni chegirib tashlagandan keyin har bir dollar daromadning sof foyda qismini aks ettirib, biznesning umumiy samaradorligini tavsiflaydi. RNA tahrirlash platformasini ishlab chiqayotgan Korro Bio, Inc. (KRRO) uchun ushbu sof foyda marjasi hozirda kam uchraydigan kasalliklar terapiyasi bo'yicha investitsiya bosqichini aks ettirmoqda, bu esa investorlarga kompaniyaning kelgusidagi daromadli bo'lish yo'lini kuzatish imkonini beradi.

Raqobatdosh kompaniyalar tahlili

TEM: Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha marjinallik Qiagen QGEN|IONS (Isis Pharmaceuticals) - Sotuvning sof marjinal rentabelligi|Repligen Inc. - Sof foyda marjasi|Sotuvning sof marjinal rentabelligi RNA|CRSP - Sof marja|GeneDx - Sof foyda bo'yicha sotuv rentabelligi|Sof foyda normasi RARE|Beam Tx - Sotuvning sof marjinal rentabelligi|SRPT - Sotuvning sof marjinal rentabelligi|TWST (Twist Bio) - Sof foyda bo'yicha sotuv rentabelligi|Sotuvning sof rentabelligi TXG|Sof foyda bo'yicha sotuv rentabelligi NTLA|Stoke Therapeutics Inc (STOK) - Kompaniya sotuv marjasi|Sotuvning sof marjinal rentabelligi BLFS|Sof marja WVE (Wave Life Sciences Corp)|Sof marja Maze Therapeutics MAZE|Sof foyda normasi SION|PRME - Sof marja|Kompaniya sotuv marjasi Taysha TSHA|QURE: Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha sotuv rentabelligi MeiraGTx PLC|RGNX (REGENXBIO Inc) - Sotuvning sof marjinal rentabelligi|solidbio.com (SLDB) - Kompaniya sotuv marjasi|Sof marja Ocugen Corp (OCGN)|Pacific Biosciences of California, Inc. - Sotuvning sof rentabelligi|Benitec Biopharma - Sof foyda bo'yicha sotuv rentabelligi|DSGN: Sotuvning sof rentabelligi|RCKT: Sof foyda bo'yicha sotuv rentabelligi|FDMT - Sotuvning sof marjinal rentabelligi|LXEO: Sotuvning sof marjinal rentabelligi|Editas Medicine (EDIT) - Sotuvning sof marjinal rentabelligi|Sof marja Silence Therapeutics Inc.|Sotuvning sof rentabelligi PRQR (proqr.com)|Sof marja Codexis Bio (CDXS)|Sotuvning sof marjinal rentabelligi sangamo.com (SGMO)|Sof marja nautilus.bio NAUT|Kompaniya sotuv marjasi Metagenomi, Inc (MGX)|Precision BioSciences Inc. - Sotuvning sof marjinal rentabelligi|GBIO - Sotuvning sof marjinal rentabelligi|BOLD: Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi XCUR|Sof marja Imunon|Phio Pharmaceuticals - Sof foyda marjasi|Sof marja Mustang Bio, Inc. (MBIO)|Kompaniya sotuv marjasi TransCode Therapeutics, Inc.|Sof marja Bionano Genomics BNGO|Sof foyda normasi APDN|BLUE - Sof marja|Sof foyda marjasi IPA|Omega Therapeutics, Inc. (OMGA) - Sof marja|Singular Genomics Corp (OMIC) - Sotuvning sof marjinal rentabelligi|RGLS (Regulus Therapeutics, Inc.) - Sotuvning sof marjinal rentabelligi|SYRS: Sof foyda normasi|Sof foyda bo'yicha sotuv rentabelligi TBIO (Telesis Bio Inc.)|Sotuvning sof marjinal rentabelligi TRACON Pharmaceuticals Inc. (TCON)|Sof marja Unity Bio UBX